LL Medica

The company's strategy is to is to achieve stable growth in the long term, taking a responsibility for its customers, employees, partners and the society as a whole. We rely solely on the high level of professionalism, ethics and correctness towards our partners in order to achieve all the goals of the company in the present, short and long term.

All projects included in the company's investment program are implemented through innovative solutions and in accordance with all international quality standards. The strategy of Long Life is: The Company to be developed as an international public company and to become a standard for the Bulgarian capital market. The clearness and transparency of the company's future development in the field of science, as well as the application of international standards and international audits, together with the use of the most up-to-date high-tech information and digital solutions guarantee that it is a new type of company with great potential for development .

The Management Board has adopted a long-term strategy that includes the following key areas:

  • Increasing the efficiency of the use of technologies related to human health and life extension

  • Developing new technologies related to human health and life extension

  • Investing in the ongoing development of the company's network and brand

  • Investing in digital software for communication between specialists, partners and clients of the company

  • Combining science and business, as a company's permanent priority

  • Distribution network expansion

  • Expanding the product range

  • Increasing productivity by using key elements of digital health, precisely the use of: Wireless devices, hardware sensors, software sensor technologies, microprocessors and integrated circuits, the Internet, social networks, mobile cellular and body area networks, health information technology, genetics and personal genetic information.